Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688180 Shanghai Junshi Biosciences Co., Ltd.
- 28.69
- -0.28-0.97%
Market Closed May 12 15:00 CST
28.28BMarket Cap-22.93P/E (TTM)
29.35High28.24Low67.79KlotVolume29.23Open28.97Pre Close193.87MTurnover0.89%Turnover RatioLossP/E (Static)985.69MShares38.3652wk High5.03P/B21.93BFloat Cap23.0852wk Low34.76Limit Up764.55MShs Float220.40Historical High23.18Limit Down3.83%Amplitude23.08Historical Low--Dividend TTM28.60Avg Price32.97KlotAsk--Div YieldTTM100Lot Size30.99KlotBid
Shanghai Junshi Biosciences Co., Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 31.46%500.59M | 29.67%1.95B | 28.87%1.27B | 17.37%786.06M | 49.24%380.8M | 3.38%1.5B | -19.04%986.46M | -29.21%669.7M | -59.47%255.15M | -63.89%1.45B |
| Operating revenue | 31.46%500.59M | 29.67%1.95B | 28.87%1.27B | 17.37%786.06M | 49.24%380.8M | 3.38%1.5B | -19.04%986.46M | -29.21%669.7M | -59.47%255.15M | -63.89%1.45B |
| Total operating cost | 11.25%782.54M | -15.64%3.22B | -8.80%2.26B | -19.07%1.43B | -21.64%703.38M | -7.09%3.81B | -15.45%2.48B | -8.12%1.77B | -11.32%897.62M | -13.23%4.1B |
| Operating cost | -13.13%93.9M | -24.08%410.68M | -3.42%325.34M | -16.55%210.42M | 26.41%108.09M | 7.27%540.98M | -21.17%336.85M | -17.77%252.16M | -48.07%85.51M | -59.48%504.31M |
| Operating tax surcharges | 5.64%5.96M | 13.14%22.29M | 27.52%17.13M | 32.31%11.61M | 57.60%5.64M | 89.23%19.7M | 90.98%13.44M | 80.70%8.78M | -2.49%3.58M | 47.35%10.41M |
| Operating expense | 17.79%225.68M | 16.60%984.55M | 23.31%683.63M | 14.59%427.55M | 4.91%191.59M | 17.98%844.36M | 7.91%554.41M | 21.39%373.13M | 13.69%182.62M | -2.57%715.7M |
| Administration expense | -21.32%97.02M | -2.47%523.2M | -1.71%353.24M | 3.19%239.72M | 8.99%123.31M | -5.74%536.44M | -14.33%359.4M | -20.20%232.3M | -36.74%113.14M | -11.36%569.09M |
| Financial expense | 704.95%9.39M | 99.78%-144.41K | 113.62%7.54M | 97.79%-930.6K | 89.58%-1.55M | 17.13%-67.09M | 22.42%-55.34M | 1.51%-42.15M | -129.95%-14.89M | -358.10%-80.95M |
| -Interest expense (Financial expense) | 43.85%16.81M | 90.99%43.94M | 64.76%32.91M | 62.62%20.69M | 39.08%11.68M | 0.13%23.01M | 9.11%19.98M | 28.52%12.72M | 73.70%8.4M | 43.14%22.98M |
| -Interest Income (Financial expense) | 46.93%-7.41M | 56.12%-43.63M | 57.94%-32.65M | 55.56%-24.45M | 50.83%-13.96M | -62.95%-99.43M | -84.14%-77.61M | -104.50%-55.03M | -254.24%-28.39M | -96.97%-61.02M |
| Research and development | 26.89%350.58M | -34.18%1.28B | -31.19%874.27M | -42.40%546.38M | -47.64%276.29M | -18.74%1.94B | -22.34%1.27B | -10.70%948.6M | 3.28%527.66M | 15.26%2.38B |
| Credit Impairment Loss | -3.96%2.59M | 183.99%19.72M | 1,103.47%11.17M | 1,028.25%10.42M | 282.79%2.7M | -49,671.33%-23.48M | -1,064.91%-1.11M | -2,839.46%-1.12M | -5,764.99%-1.47M | -113.80%-47.18K |
| Asset Impairment Loss | -191.96%-5.81M | 30.19%-88.18M | 89.67%-3.64M | 98.95%-381.61K | 133.19%6.32M | -474.83%-126.31M | -89.48%-35.25M | -162.77%-36.36M | -578.86%-19.04M | -61.01%-21.97M |
| Other net revenue | ||||||||||
| Fair value change income | 74.95%-289.23K | 68.04%-47.68M | 34.45%-30.05M | -15.78%-32.15M | 81.15%-1.15M | -1,508.11%-149.18M | -174.26%-45.85M | -21.15%-27.77M | ---6.12M | -108.21%-9.28M |
| Invest income | -40.18%-10.37M | -131.83%-23.55M | 61.78%-17.15M | 0.84%-27.84M | 46.62%-7.4M | 276.45%73.99M | -139.36%-44.87M | -3,399.72%-28.07M | -990.26%-13.86M | 11.14%-41.93M |
| -Including: Investment income associates | -67.60%-12.29M | 42.09%-35.03M | 50.22%-24.44M | 12.63%-28.22M | 53.06%-7.34M | 14.85%-60.48M | -2.63%-49.1M | -14.36%-32.31M | 42.74%-15.63M | -46.57%-71.03M |
| Asset deal income | -68.18%7.55M | -56.55%12.78M | 2,047.14%12.89M | 2,432.51%12.94M | --23.72M | 30.32%29.41M | -98.14%600.42K | -98.41%510.9K | ---- | 2,675.87%22.57M |
| Other revenue | 18.17%6.56M | 17.24%55.63M | 21.99%47.61M | -70.20%10.02M | -88.83%5.55M | 38.77%47.44M | 97.44%39.03M | 309.05%33.63M | 716.42%49.75M | -62.79%34.19M |
| Operating profit | 3.80%-281.72M | 45.52%-1.34B | 38.68%-969.12M | 41.87%-675.69M | 53.75%-292.84M | 7.82%-2.46B | 7.90%-1.58B | -18.74%-1.16B | -67.56%-633.22M | -377.53%-2.67B |
| Add:Non operating Income | -59.99%6.87K | -42.46%2.25M | -77.66%877.77K | -77.34%818.41K | 281.31%17.16K | 472.92%3.91M | 1,944.23%3.93M | 19,338.32%3.61M | -38.20%4.5K | 758.44%683.04K |
| Less:Non operating expense | 37.45%5.13M | -45.02%20.98M | -47.23%16.4M | -48.79%9.29M | -12.01%3.73M | 219.30%38.17M | 181.50%31.08M | 62.15%18.14M | 125.52%4.24M | -67.52%11.95M |
| Total profit | 3.28%-286.84M | 45.52%-1.36B | 38.75%-984.64M | 41.86%-684.16M | 53.48%-296.55M | 6.93%-2.49B | 6.91%-1.61B | -18.87%-1.18B | -67.85%-637.45M | -349.95%-2.68B |
| Less:Income tax cost | -979.45%-27.25M | -48.74%22.55M | 107.79%4.08M | 107.03%3.55M | 43.05%3.1M | 147.25%43.99M | -782.01%-52.39M | -634.45%-50.49M | -94.77%2.17M | -168.70%-93.11M |
| Net profit | 13.37%-259.59M | 45.57%-1.38B | 36.42%-988.73M | 38.94%-687.71M | 53.15%-299.65M | 1.87%-2.54B | 10.34%-1.56B | -12.70%-1.13B | -51.86%-639.62M | -253.72%-2.58B |
| Net profit from continuing operation | 13.37%-259.59M | 45.57%-1.38B | 36.42%-988.73M | 38.94%-687.71M | 53.15%-299.65M | 1.87%-2.54B | 10.34%-1.56B | -12.70%-1.13B | -51.86%-639.62M | -253.72%-2.58B |
| Less:Minority Profit | -48.69%-24.71M | 60.68%-99.18M | 58.22%-61.96M | 66.84%-42.75M | 82.72%-16.62M | -28.68%-252.26M | -6.08%-148.31M | -48.13%-128.92M | -287.96%-96.19M | -1,936.83%-196.03M |
| Net profit of parent company owners | 17.01%-234.88M | 43.90%-1.28B | 34.12%-926.77M | 35.34%-644.95M | 47.92%-283.03M | 4.38%-2.28B | 11.78%-1.41B | -9.32%-997.41M | -37.09%-543.43M | -231.26%-2.39B |
| Earning per share | ||||||||||
| Basic earning per share | 17.24%-0.24 | 43.97%-1.3 | 34.27%-0.94 | 35.64%-0.65 | 47.27%-0.29 | 10.77%-2.32 | 18.29%-1.43 | -1.00%-1.01 | -25.00%-0.55 | -220.99%-2.6 |
| Diluted earning per share | 17.24%-0.24 | 43.97%-1.3 | 34.27%-0.94 | 35.64%-0.65 | 47.27%-0.29 | 10.77%-2.32 | 18.29%-1.43 | -1.00%-1.01 | -25.00%-0.55 | -220.99%-2.6 |
| Other composite income | -1,296.93%-10.2M | 75.74%-17.87M | 5.50%-47.94M | 36.24%-24.34M | 103.11%852.57K | -7.35%-73.66M | -139.40%-50.73M | 62.92%-38.18M | 45.74%-27.45M | -814.64%-68.62M |
| Other composite income of parent company owners | -1,296.93%-10.2M | 75.74%-17.87M | 5.50%-47.94M | 36.24%-24.34M | 103.11%852.57K | -7.35%-73.66M | -139.40%-50.73M | 62.92%-38.18M | 45.74%-27.45M | -814.64%-68.62M |
| Total composite income | 9.71%-269.79M | 46.42%-1.4B | 35.44%-1.04B | 38.85%-712.05M | 55.21%-298.8M | 1.63%-2.61B | 8.54%-1.61B | -5.63%-1.16B | -41.40%-667.07M | -267.95%-2.65B |
| Total composite income of parent company owners | 13.15%-245.08M | 44.90%-1.3B | 33.13%-974.71M | 35.37%-669.3M | 50.57%-282.18M | 4.05%-2.36B | 9.80%-1.46B | -1.99%-1.04B | -27.72%-570.88M | -245.37%-2.46B |
| Total composite income of minority owners | -48.69%-24.71M | 60.68%-99.18M | 58.22%-61.96M | 66.84%-42.75M | 82.72%-16.62M | -28.68%-252.26M | -6.08%-148.31M | -48.13%-128.92M | -287.96%-96.19M | -1,936.83%-196.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting